Eur Heart J 37(23):18501858 Heymans S, Lakdawala NK, Tschpe C, Klingel K (2023) Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches
The federal public comment period closed on FDA's proposal to keep semaglutide, tirzepatide, and liraglutide off the 503B bulk list
The results of these studies and the related meta-analysis report a very interesting and surprising finding: the possibility that an old therapeutic regimen, which all current guidelines suggest should be removed from the clinical practice because it is outdated and ineffective, can be effective again when combined with a new modality of acid-inhibition
Yokoyama Y, Estok TM,Wild R
CagriSema data from body composition scans in REDEFINE 1 showed that approximately 67% of total weight loss came from fat mass and 33% from lean soft tissue mass
No single milk thistle brand on our list fully satisfies all of the above sub-criteria, but HUM Nutrition comes the closest